180
Views
9
CrossRef citations to date
0
Altmetric
Articles

Efficacy of Dipeptide-Coated Magnetic Nanoparticles in Lung Cancer Models Under Pulsed Electromagnetic Field

, , , , , , , , , & show all
Pages 431-442 | Received 09 Jan 2017, Accepted 10 Apr 2017, Published online: 24 May 2017

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87–108.
  • Huang G, Zhang C, Li S, Khemtong C, Yang SG, Tian R, et al. A novel strategy for surface modification of superparamagnetic iron oxide nanoparticles for lung cancer imaging. J Mater Chem 2009;19:6367–6372.
  • Sun C, Lee JS, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv drug Deliv Rev 2008;60:1252–1265.
  • Peng X, Shin DM, Chen H, Mao H, Huang J. Targeted Magnetic Iron Oxide Nanoparticles for Tumor Imaging and Therapy. INTECH: Open Access Publisher; 2011.
  • Wu W, He Q, Jiang C. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nanoscale Res Lett 2008;3(11):397–415.
  • Hilger I. In vivo applications of magnetic nanoparticle hyperthermia. Int J Hyperthermia 2013;29(8):828–834.
  • Barry SE. Challenges in the development of magnetic particles for therapeutic applications. Int J Hyperthermia 2008;24(6):451–466.
  • Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 2006;67(1):55–60.
  • McBain SC, Yiu HH, Dobson J. Magnetic nanoparticles for gene and drug delivery. Int J Nanomedicine 2008;3(2):169–180.
  • Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 2008;24(6):467–474.
  • Panda JJ, Kaul A, Kumar S, Alam S, Mishra AK, Kundu GC, et al. Modified dipeptide-based nanoparticles: vehicles for targeted tumor drug delivery. Nanomedicine (Lond) 2013;8(12):1927–1942.
  • Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 1981;17:1247–1248.
  • Azzam EI, de Toledo SM, Little JB. Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A. 2001;98(2):473–478.
  • Li X, Du X, Huo T, Liu X, Zhang S, Yuan F. Specific targeting of breast tumor by octreotide-conjugated ultra small superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner. Acta Radiol 2009;50(6):583–594.
  • Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm 2010;7(2):375–385.
  • Ahamed M, Akhtar MJ, Siddiqui MA, Ahmad J, Musarrat J, Al-Khedhairy AA, et al. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology 2011;283(2–3):101–108.
  • Xu X, Gupta S, Hu W, McGrath BC, Cavener DR. Hyperthermia induces the ER stress pathway. PloS One 2011;6(8):e23740.
  • Ge G, Wu H, Xiong F, Zhang Y, Guo Z, Bian Z, et al. The cytotoxicity evaluation of magnetic iron oxide nanoparticles on human aortic endothelial cells. Nanoscale Res Lett 2013;8(1):215.
  • Roca AG, Costo R, Rebolledo AF, Veintemillas-Verdaguer S, Tartaj P, Gonzalez-Carreno T, et al. Progress in the preparation of magnetic nanoparticles for applications in biomedicine. J Phys D; Appl Phys 2009;42(22):224002.
  • Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008;108(6):2064–2110.
  • Berti L, Woldeyesus T, Li Y, Lam KS. Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction. Langmuir 2010 Dec 7;26(23):18293–18299.
  • Hoskins C, Wang L, Cheng WP, Cuschieri A. Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols? Nanoscale Res Lett 2012;7:77.
  • Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 2005;19(7):975–983.
  • Kim JS, Yoon TJ, Yu KN, Kim BG, Park SJ, Kim HW, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 2006;89(1):338–347.
  • Jeng HA, Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J Environ Sci Health A Tox Hazard Subst Environ Eng 2006;41(12):2699–2711.
  • Balasubramanian S, Girija AR, Nagaoka Y, Iwai S, Suzuki M, Kizhikkilot V, et al. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int J Nanomedicine 2014;9:437–459.
  • Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014;14(3):199–208.
  • Eivari HA, Rahdar A. Some properties of iron oxide nanoparticles synthesized in different conditions. 2013. World Appl. Program 3:52–55.
  • Levy M, Luciani N, Alloyeau D, Elgrabli D, Deveaux V, Pechoux C, et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials 2011 Jun;32(16):3988–3999.
  • Zylicz M, King FW, Wawrzynow A. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J 2001;20(17):4634–4638.
  • Beere HM1. Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005;115(10):2633–2639.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.